Arbutus Biopharma Corp Financial Ratios — ABUS Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	-35.83	-58.05	-19.26	-98.26	-48.39	-63.28	- -	- -	- -	-51.98	-77.46	-102.36	-63.93
Return on Assets (%)	-58.08	89.33	-22.63	-40.9	-15.1	-77.75	-32.9	-24.54	-92.2	-52.55	-44.65	-34.74	-42.88	-50.65	-29.6
Return on Capital (%)	- -	1,481.18	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	144.46	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	-15.93	-27.92	-38.75	-158.9	-121.28	-4,008.18	-485.76	-874.5	-858.26	-586.74	100	100	100	100	100
EBITDA Margin (%)	-57.74	242.35	-74.61	-216.97	-234.86	-6,653.25	-636.5	-1,143.67	-1,153.17	-799.7	-636.12	-158.37	-422.41	-1,111.55	-189.51
Operating Margin (%)	-63.61	236.21	-78.58	-220.5	-237.39	-6,726.49	-655.44	-1,180.35	-1,186.91	-828.3	-652.07	-162.03	-430.15	-1,133.92	-192.08
Incremental Operating Margin (%)	- -	-1,626.06	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-59.98	209.93	-90.93	-259.73	-338.99	-32,807.91	-1,016.2	-1,031.83	-2,767.91	-921.97	-693.91	-166.62	-401.57	-1,133.04	-237.88
Profit Margin (%)	-59.98	209.93	-90.93	-259.73	-269.45	-25,765.53	-788.91	-959.8	-2,557.36	-921.97	-693.91	-178.01	-401.57	-1,133.04	-237.88
Net Income to Common Margin (%)	-59.98	209.93	-90.93	-259.73	-269.45	-25,765.53	-797.42	-1,129.54	-2,742.84	-921.97	-693.91	-178.01	-401.57	-1,133.04	-237.88
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	1.07	15.03	6.76	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	-35.83	-58.05	-19.26	-98.26	-47.87	-53.77	- -	- -	- -	-51.98	-77.46	-102.36	-63.93

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	12	12	- -	3	3	3	2	2	1	1
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1
LT Debt	- -	- -	- -	- -	- -	12	12	- -	3	3	2	2	1	1	- -
Total Debt/EBITDA	- -	- -	- -	- -	- -	-0.12	-0.18	- -	-0.05	-0.05	-0.04	-0.04	-0.02	-0.02	-0.03
Net Debt/EBITDA	0.93	-1.38	5.96	2.23	3.05	0.12	0.62	0.54	0.46	0.95	1.56	0.5	0.34	0.53	0.67
Total Debt/EBIT	- -	- -	- -	- -	- -	-0.12	-0.17	- -	-0.05	-0.05	-0.04	-0.03	-0.02	-0.02	-0.03
Net Debt/EBIT	0.84	-1.41	5.65	2.19	3.02	0.11	0.6	0.53	0.45	0.91	1.53	0.49	0.34	0.52	0.67
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	-260.94	-300.85	-32.88	-13.78	-24.47	-35.8	-166.95	-500.69	-275.13
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	-288.77	-305.88	-33.16	-13.84	-24.75	-36.1	-169.15	-502.01	-275.13
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	-268.7	-310.5	-33.84	-14.28	-25.08	-36.63	-170.01	-510.76	-278.88
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	2	4	3	2	- -	- -	- -
Common Equity/Total Assets	-181.16	54.8	69.27	71.2	79.64	77.79	58.2	32.55	-67.8	-43.79	74.47	58.81	50.67	48.18	43.71
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	5.91	6.58	- -	4.15	2.54	1.32	1.33	1.27	0.83	0.26
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	5.29	6.01	- -	4.37	2.81	1.44	1.55	1.79	1.24	0.47
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	4.35	5.06	- -	2.86	1.89	1.09	0.93	0.93	0.61	0.21
Total Debt/Equity (%)	- -	- -	- -	- -	- -	5.91	6.58	- -	4.62	2.93	1.54	1.6	1.67	1.32	0.97
Total Debt/Capital (%)	- -	- -	- -	- -	- -	5.29	6.01	- -	4.86	3.23	1.69	1.87	2.36	1.99	1.77
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	4.35	5.06	- -	3.18	2.18	1.28	1.12	1.22	0.98	0.79
Net Debt to Equity	-172.79	-114.92	-116.09	-82	-30.45	-5.62	-23.18	-18.45	-43.71	-51.24	-64.5	-22.49	-24.79	-37.31	-23.52
Net Debt/Capital (%)	26.6	258.36	360.87	-603.92	-41.65	-5.62	-29.06	-22.61	-85.28	-130.24	-239.54	-35.64	-54.03	-127.87	-74.74
EBITDA	-10	34	-12	-32	-55	-99	-68	-68	-69	-55	-70	-62	-77	-69	-27
EBITDA-CapEx	-10	34	-12	-33	-57	-103	-75	-69	-70	-56	-71	-62	-78	-69	-27
Operating Income (Loss)	-11	33	-12	-33	-55	-100	-70	-70	-71	-57	-72	-63	-78	-70	-27

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.31	4.29	5.49	5.55	17.14	12.33	8.64	11.09	11.6	12.92	13.84	4.47	5.6	7.85	15.23
Current Ratio	1.69	4.68	5.62	5.76	17.38	12.52	8.84	11.5	11.99	13.38	14.32	4.6	5.87	8.15	15.73
Quick Ratio	1.51	4.61	5.52	5.68	17.27	12.4	8.7	11.22	11.76	13.06	13.92	4.51	5.68	8.01	15.47
CFO/Avg Current Liab	-1.05	3.7	-0.57	-0.76	-3.66	-5.47	-3.86	-5.25	-7.45	-5.92	-6.51	-1.6	-3.11	-3.4	-3.67
Common Equity/Total Assets	-181.16	54.8	69.27	71.2	79.64	77.79	58.2	32.55	-67.8	-43.79	74.47	58.81	50.67	48.18	43.71
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	5.91	6.58	- -	4.15	2.54	1.32	1.33	1.27	0.83	0.26
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	5.29	6.01	- -	4.37	2.81	1.44	1.55	1.79	1.24	0.47
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	4.35	5.06	- -	2.86	1.89	1.09	0.93	0.93	0.61	0.21
Total Debt/Equity (%)	- -	- -	- -	- -	- -	5.91	6.58	- -	4.62	2.93	1.54	1.6	1.67	1.32	0.97
Total Debt/Capital (%)	- -	- -	- -	- -	- -	5.29	6.01	- -	4.86	3.23	1.69	1.87	2.36	1.99	1.77
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	4.35	5.06	- -	3.18	2.18	1.28	1.12	1.22	0.98	0.79
CFO/Total Liabilities	-92.16	281.83	-53.8	-41.21	-34.25	-79.39	-88.94	-245.26	-216.54	-146.5	-192.7	-60.37	-223.89	-188.84	-219.69
CFO/CapEx	-129.7	2,193.87	-9.29	-11.76	-24.65	-14.49	-6.7	-59.64	-120.55	-224.63	-83.48	-69.05	-85.25	-356.32	- -
Altman's Z-Score	-25.64	2.71	3.21	4.51	-0.91	-6.14	-4.24	-2.9	-11.16	-6.38	-0.92	-5.16	-6.64	-4.4	10.56

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	8.04	14.56	25.95	14.8	15.99	2.33	31.7	6.49	4.56	5.5	9.94	34.67	11.6	2.95	7.3
Days Sales Outstanding	45.38	25.07	14.07	24.65	22.82	156.8	11.51	56.27	80	66.41	36.72	10.53	31.47	123.77	49.97
Inventory Turnover	258.64	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	1.41	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	30.74	17.48	21.22	23.74	22.13	21.03	24.1	22.37	20.61	17.61	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	11.87	20.88	17.2	15.37	16.49	17.36	15.15	16.31	17.71	20.72	- -	- -	- -	- -	- -
Cash Conversion Cycle	34.92	4.19	-3.14	9.28	6.33	139.44	-3.63	39.95	62.29	45.69	- -	- -	- -	- -	- -
Inventory to Cash Days	43.97	25.07	14.07	24.65	22.82	156.8	11.51	56.27	80	66.41	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	17	68	122	340	202	130	273	212	159	269	413	352	415	607	922
- Cash & Cash Equivalents	9	47	69	72	167	23	54	37	32	52	109	31	26	36	18
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	50	126	137	149	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	12	12	- -	3	3	3	2	2	1	1
Enterprise Value	8	21	53	228	21	11	209	213	209	298	261	207	291	486	831
Total Capital	-25	29	50	84	567	227	200	200	69	92	155	117	75	65	42
Total Debt/Capital (%)	- -	- -	- -	- -	- -	5.29	6.01	- -	4.86	3.23	1.69	1.87	2.36	1.99	1.77
Total Debt / EV	- -	- -	- -	- -	- -	1.05	0.06	- -	0.02	0.01	0.01	0.01	0.01	- -	- -
EV/Sales	0.47	1.49	3.44	15.23	0.9	7.66	19.5	35.88	34.69	43.15	23.71	5.3	16.02	78.69	59
EV/EBITDA	- -	0.62	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	0.63	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	0.64	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	0.64	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	17	71	122	340	202	130	273	212	159	269	413	352	415	607	922
Diluted Enterprise Value	8	24	53	268	36	119	281	301	268	369	307	323	390	572	904
EV per Share	0.71	1.53	3.48	10.15	0.46	0.22	3.86	3.86	3.65	3.93	2.45	1.37	1.75	2.62	4.34
TTM Sales	17	14	15	15	23	1	11	6	6	7	11	39	18	6	14
TTM EBITDA	-10	34	-12	-32	-55	-99	-68	-68	-69	-55	-70	-62	-77	-69	-27
TTM Operating Income	-11	33	-12	-33	-55	-100	-70	-70	-71	-57	-72	-63	-78	-70	-27
TTM Cash Flow to Firm	-8	33	-7	-12	-56	-58	-48	-68	-69	-47	-65	-34	-85	-65	-40
TTM Free Cash Flow to Firm	-8	33	-6	-11	-54	-54	-41	-67	-68	-47	-64	-33	-84	-65	-40

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-2.18	2.16	-20.29	-29.91	-3.74	-2.41	-6.6	-3.17	-2.25	-5.26	-6.19	-10.09	-4.89	-9.39	-23.25
EV/EBIT	- -	0.63	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	8	21	53	228	21	11	209	213	209	298	261	207	291	486	831
Low Price	1.29	1.52	4.18	7.65	4.25	2.35	2.35	3.2	0.82	0.88	2.43	1.85	1.69	2.21	2.71
EV/Sales	0.47	1.49	3.44	15.23	0.9	7.66	19.5	35.88	34.69	43.15	23.71	5.3	16.02	78.69	59
EV/EBITDA	- -	0.62	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	2.3	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-3.29	1.42	-6.36	-9.49	-8.99	-0.51	-2.6	-5.38	-0.84	-3.24	-4.93	-5.63	-5.39	-8.72	-21.25
Price/Earnings High	-8.91	3.14	-12.43	-18.19	-19.38	-0.76	-5.23	-10.38	-1.64	-10.73	-9.06	-8.71	-7.18	-12.53	-29.17
Price/Earnings Low	-1.45	0.7	-4.55	-4.42	-3.08	-0.32	-1.49	-2.64	-0.28	-1.05	-3.39	-4.02	-3.85	-5.87	-15.5
Price/Book Value	-0.68	2.36	2.46	4.04	0.36	0.61	1.98	2.86	-2.22	-4.49	2.71	3.06	5.67	9.57	22.28
Price/Book Value Average	-1.34	1.46	1.8	4.38	0.99	0.9	1.6	4.87	-1.93	-3.44	2.47	3.4	5.37	9.61	17.21
Price/Book Value High	-3.62	3.23	3.52	8.39	2.14	1.35	3.23	9.39	-3.79	-11.4	4.53	5.27	7.14	13.81	23.63
Price/Book Value Low	-0.59	0.72	1.29	2.04	0.34	0.58	0.92	2.39	-0.65	-1.11	1.7	2.43	3.83	6.46	12.56
Price/Tangible Book Value	3.26	1.66	2.06	3.86	6.22	1.64	5.5	27.19	-2.46	-5.67	2.44	2.57	3.91	6.23	12.04
Price/Tangible Book Value Average	6.38	1.03	1.51	4.19	17.34	2.45	4.46	46.37	-2.14	-4.36	2.22	2.86	3.71	6.26	9.3
Price/Tangible Book Value High	17.26	2.27	2.95	8.02	37.36	3.67	8.98	89.44	-4.2	-14.42	4.08	4.42	4.93	9	12.76
Price/Tangible Book Value Low	2.8	0.51	1.08	1.95	5.94	1.57	2.56	22.72	-0.73	-1.41	1.52	2.04	2.65	4.21	6.78
Price/Sales	1.01	4.83	7.89	22.73	8.69	87.18	25.53	35.63	26.4	38.94	37.61	9.01	22.87	98.35	65.44
Price/Sales Average	1.98	2.98	5.78	24.65	24.23	130.21	20.7	60.77	22.96	29.89	34.24	10.02	21.65	98.81	50.55
Price/Sales High	5.35	6.6	11.3	47.24	52.21	194.99	41.71	117.21	45.12	98.93	62.85	15.51	28.82	141.97	69.39
Price/Sales Low	0.87	1.48	4.14	11.48	8.3	83.62	11.88	29.77	7.79	9.65	23.5	7.16	15.46	66.47	36.87
Price/Cash Flow	-2.17	2.07	-18.1	-27.37	-3.59	-2.25	-5.62	-3.12	-2.24	-5.23	-6.12	-9.95	-4.83	-9.36	-23.25
Price/Cash Flow Average	-4.24	1.28	-13.27	-29.67	-10	-3.35	-4.55	-5.32	-1.94	-4.02	-5.57	-11.05	-4.57	-9.4	-17.96
Price/Cash Flow High	-11.48	2.83	-25.94	-56.87	-21.55	-5.02	-9.18	-10.27	-3.82	-13.3	-10.23	-17.12	-6.08	-13.51	-24.65
Price/Cash Flow Low	-1.86	0.63	-9.49	-13.82	-3.43	-2.15	-2.61	-2.61	-0.66	-1.3	-3.82	-7.9	-3.26	-6.33	-13.1
Price/Free Cash Flow Average	-4.28	1.33	-14.87	-32.43	-10.43	-3.6	-5.35	-5.41	-1.96	-4.04	-5.64	-11.22	-4.63	-9.43	-17.96
Price/Free Cash Flow High	-11.57	2.95	-29.07	-62.15	-22.46	-5.39	-10.79	-10.44	-3.85	-13.36	-10.35	-17.37	-6.16	-13.55	-24.65
Price/Free Cash Flow Low	-1.88	0.66	-10.64	-15.1	-3.57	-2.31	-3.07	-2.65	-0.66	-1.3	-3.87	-8.01	-3.3	-6.34	-13.1
EV/Sales Average	1.44	- -	1.34	19.82	17.07	122.55	21.4	75.78	41.07	44.37	24.53	9.28	20.3	93.14	49.32
EV/Sales High	4.81	3.26	6.86	42.41	45.04	187.33	42.41	132.22	63.22	113.42	53.14	14.78	27.47	136.29	68.16
EV/Sales Low	0.33	- -	- -	6.65	1.14	75.96	12.58	44.77	25.9	24.14	13.79	6.42	14.11	60.79	35.64
EV/EBITDA Average	-2.5	-0.14	-1.79	-9.13	-7.27	-1.84	-3.36	-6.63	-3.56	-5.55	-3.86	-5.86	-4.81	-8.38	-26.03
EV/EBITDA High	-8.33	1.35	-9.19	-19.55	-19.18	-2.82	-6.66	-11.56	-5.48	-14.18	-8.35	-9.33	-6.5	-12.26	-35.97
EV/EBITDA Low	-0.58	-0.77	0.41	-3.07	-0.48	-1.14	-1.98	-3.91	-2.25	-3.02	-2.17	-4.06	-3.34	-5.47	-18.81
EV/EBIT Average	-2.27	-0.15	-1.7	-8.99	-7.19	-1.82	-3.26	-6.42	-3.46	-5.36	-3.76	-5.73	-4.72	-8.21	-25.68
EV/EBIT High	-7.56	1.38	-8.73	-19.23	-18.97	-2.79	-6.47	-11.2	-5.33	-13.69	-8.15	-9.12	-6.39	-12.02	-35.48
EV/EBIT Low	-0.52	-0.79	0.39	-3.02	-0.48	-1.13	-1.92	-3.79	-2.18	-2.91	-2.11	-3.96	-3.28	-5.36	-18.56
Last Price	1.5	4.96	7.97	15.15	4.45	2.45	5.05	3.83	2.78	3.55	3.89	2.33	2.5	3.27	4.81
High Price	7.94	6.78	11.42	31.48	26.73	5.48	8.25	12.6	4.75	9.02	6.5	4.01	3.15	4.72	5.1
Enterprise Value Average	24	-5	21	296	397	183	229	450	247	307	270	362	368	575	695
Enterprise Value High	81	46	106	634	1,048	279	454	786	380	784	584	577	498	841	960
Enterprise Value Low	6	-26	-5	99	26	113	135	266	156	167	152	251	256	375	502

Shares Outstanding	12	14	19	22	55	55	55	57	65	91	145	157	170	190	193
Diluted Weighted Avg Shares	11	14	15	22	45	53	54	55	57	76	106	151	166	186	192
Basic Weighted Avg Shares	11	14	15	22	45	53	54	55	57	76	106	151	166	186	192
Revenue per Share	1.49	1.03	1.01	0.67	0.51	0.03	0.2	0.11	0.11	0.09	0.1	0.26	0.11	0.03	0.07
EBITDA per Share	-0.86	2.49	-0.75	-1.45	-1.2	-1.87	-1.26	-1.23	-1.21	-0.73	-0.66	-0.41	-0.46	-0.37	-0.14
Operating Income per Share	-0.94	2.43	-0.79	-1.47	-1.22	-1.89	-1.3	-1.27	-1.25	-0.76	-0.67	-0.42	-0.47	-0.38	-0.14
Basic EPS, GAAP	-0.89	2.16	-0.92	-1.73	-1.38	-7.24	-1.58	-1.21	-2.89	-0.84	-0.72	-0.46	-0.44	-0.38	-0.17
Basic EPS from Cont Ops	-0.89	2.16	-0.92	-1.73	-1.38	-7.24	-1.56	-1.03	-2.69	-0.84	-0.72	-0.46	-0.44	-0.38	-0.17
Diluted EPS, GAAP	-0.89	2.07	-0.92	-1.73	-1.38	-7.24	-1.58	-1.21	-2.89	-0.84	-0.72	-0.46	-0.44	-0.38	-0.17
Diluted EPS from Cont Ops	-0.89	2.07	-0.92	-1.73	-1.38	-7.24	-1.56	-1.03	-2.69	-0.84	-0.72	-0.46	-0.44	-0.38	-0.17
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.69	2.4	-0.44	-0.55	-1.24	-1.09	-0.9	-1.23	-1.24	-0.68	-0.64	-0.23	-0.52	-0.35	-0.21
Free Cash Flow per Basic Share	-0.7	2.4	-0.49	-0.6	-1.29	-1.17	-1.03	-1.25	-1.25	-0.68	-0.64	-0.24	-0.52	-0.35	-0.21
Cash & Equivalents per Share	0.79	3.43	4.49	5	3.99	2.46	2.34	2.25	1.59	1.63	1.46	0.97	0.76	0.66	0.48
Book Value per Share	-2.19	2.1	3.25	3.75	12.48	4.05	2.55	1.34	-1.25	-0.79	1.43	0.76	0.44	0.34	0.22
Tangible Book Value per Share	0.46	2.98	3.87	3.92	0.72	1.49	0.92	0.14	-1.13	-0.63	1.59	0.91	0.64	0.52	0.4

Arbutus Biopharma Corp

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)